In degenerative and extra-articular rheumatic diseases with pain in and around the joints due to changes in joint cartilage or injuries to tendons, ligaments and muscles, the Orthokin therapeutic method is a unique way of treating pain without added medicines or other foreign substances. It is based on the application of autologous (the patient’s own) serum enriched with anti-inflammatory proteins and growth factors to diseased or damaged tissue. This treatment uses nothing other than the patient’s own endogenous proteins and healing factors.
What is Orthokin therapy?
Orthokin Orthokin therapeutic method is a unique way of treating joint pain due to degenerative diseases, as well as injuries of tendons, ligaments and muscles, without the addition of medications and other foreign substances. It is based on the application of autologous (own) serum enriched with anti-inflammatory proteins and growth factors which is applied into the diseased or damaged tissue.
This method of treatment uses nothing other than the patient's own endogenous proteins and healing factors. Anti-inflammatory and regenerative results are long-lasting due to blocking the binding of inflammation factors (interleukin 1) to cells, thereby reducing damage to cartilage and other damaged tissues. Growth factors stimulate tissue recovery, epithelialisation, spontaneous wound closure, connective tissue formation, and fibroblast activation at the site of injury.
Orthokin The therapy has been used since 1997 and is currently used to treat their patients by around 500 licensed rheumatologists, orthopaedic surgeons, physiatrists, neurosurgeons, neurologists, anaesthesiologists and sports physicians in Europe, with a high rate of successful outcomes.
To whom should this therapy be recommended?
Recommended for treatment of joint pain resulting from osteoarthritis of the knee joint, hip, shoulder, elbow, ankle joint (I - III degree) as well as injuries of tendons, ligaments and muscles, in combination with or without surgical treatment.
How is Orthokin therapy applied?
At the beginning of the process Orthokin At the beginning of the Orthokin therapy process, the patient's blood is taken in the morning and processed under special conditions, without the addition of any chemical substances. The incubation process, which lasts 7-9h at 37°C, stimulates cells from the patient's blood to produce factors known to block inflammation (interleukin 1 receptor antagonist) and growth factors in high concentration. After the incubation process, the concentration of these factors increases up to 140 times. By centrifuging the blood, serum is separated from all formed blood elements and fibrinogen.
The processed serum, enriched with inflammation blockers and healing factors, is periodically injected into the painful area under ultrasound guidance, every 3–7 days.
Poliklinika Živanović is a licensed institution for the implementation of Orthokin therapies as new health technologies, which was approved by the Ministry of Health of the Republic of Serbia.